Atlas Venture Opportunity Fund I, L.P.
Related Filers (28)
- Atlas Venture Associates Opportunity I, LLC (38)
- Atlas Venture Associates Opportunity I, L.P. (35)
- Atlas Venture Associates X, LLC (20)
- ATLAS VENTURE ASSOCIATES X, L.P. (20)
- Atlas Venture Fund X, L.P. (19)
- Atlas Venture Fund XI, L.P. (18)
- Atlas Venture Associates XI, LLC (15)
- Atlas Venture Associates XI, L.P. (15)
- Disc Medicine, Inc. (10)
- Generation Bio Co. (8)
- Kymera Therapeutics, Inc. (6)
- Akero Therapeutics, Inc. (4)
- Xilio Therapeutics, Inc. (4)
- Day One Biopharmaceuticals, Inc. (4)
- Dyne Therapeutics, Inc. (3)
- Ikena Oncology, Inc. (3)
- Atlas Venture Associates XII, LLC (3)
- Atlas Venture Fund XII, L.P. (3)
- Atlas Venture Associates XII, L.P. (3)
- Atlas Venture Opportunity Fund II, L.P. (3)
- Vigil Neuroscience, Inc. (2)
- F-star Therapeutics, Inc. (2)
- Third Harmonic Bio, Inc. (2)
- Atlas Venture Associates Opportunity II, LLC (2)
- Atlas Venture Associates Opportunity II, LP (2)
- AVROBIO, Inc. (1)
- Replimune Group, Inc. (1)
- Magenta Therapeutics, Inc. (1)
- Show More ...
Other (6)
144
Tuesday, 1/23/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 1/10/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/15/2023
Filing for proposed sale of securities under Rule 144
D/A
Wednesday, 1/2/2019
Exempt (Private) Offering
D
Thursday, 11/29/2018
Exempt (Private) Offering
Ownership (47)
4
Friday, 2/9/2024
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/25/2024
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/16/2024
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/12/2024
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/14/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/16/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/13/2023
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/16/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/14/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/4/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/19/2022
Third Harmonic Bio, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/14/2022
Third Harmonic Bio, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/6/2022
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/22/2022
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
F-star Therapeutics, Inc.: Major Shareholders
4
Tuesday, 1/11/2022
Vigil Neuroscience, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/6/2022
Vigil Neuroscience, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 12/14/2021
Ikena Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/26/2021
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/21/2021
Xilio Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 9/29/2021
Generation Bio Co.: Statement of changes in beneficial ownership of securities
4
Friday, 9/24/2021
Generation Bio Co.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/21/2021
Generation Bio Co.: Statement of changes in beneficial ownership of securities
4
Monday, 6/28/2021
Generation Bio Co.: Statement of changes in beneficial ownership of securities
4
Monday, 6/21/2021
Generation Bio Co.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/2/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/26/2021
Day One Biopharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/1/2021
Ikena Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/25/2021
Ikena Oncology, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 2/11/2021
Gemini Therapeutics, Inc. /DE: Initial statement of beneficial ownership of securities
SC 13G
Wednesday, 2/3/2021
F-star Therapeutics, Inc.: Major Shareholders
4
Thursday, 12/17/2020
Generation Bio Co.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/23/2020
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/16/2020
Dyne Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 8/25/2020
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/20/2020
Kymera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Monday, 7/13/2020
Magenta Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/18/2020
Generation Bio Co.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/11/2020
Generation Bio Co.: Initial statement of beneficial ownership of securities
4
Monday, 2/10/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/19/2019
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/20/2019
Replimune Group, Inc.: Initial statement of beneficial ownership of securities
3
Monday, 7/29/2019
AVROBIO, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/25/2019
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/19/2019
Akero Therapeutics, Inc.: Initial statement of beneficial ownership of securities